Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Chief Scientist Goodman Spearheads Agency Response To Swine Flu

Executive Summary

FDA acting chief scientist Jesse Goodman is taking the lead role in coordinating the agency's response to the swine flu outbreak

You may also be interested in...



FDA’s Acting Chief Scientist Offers Vaccine Continuity As Goodman Departs

Jesse Goodman will become director of Georgetown University’s new Center on Medical Product Access, Safety and Stewardship while Stephen Ostroff steps up as FDA’s Acting Chief Scientist.

FDA’s Acting Chief Scientist Offers Vaccine Continuity As Goodman Departs

Jesse Goodman will become director of Georgetown University’s new Center on Medical Product Access, Safety and Stewardship while Stephen Ostroff steps up as FDA’s Acting Chief Scientist.

State Of The Science At FDA: Catching Up With Jesse Goodman

As the swine flu pandemic shows signs of leveling off, FDA Chief Scientist Jesse Goodman is ready to turn attention back to his original mission: improving the agency's scientific capacity and integrity

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS051008

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel